SABR versus conventional fractionation regimens in NSCLC
Lancet Oncol
.
2019 May;20(5):e230.
doi: 10.1016/S1470-2045(19)30175-5.
Authors
Alfredo Addeo
1
,
Lucio Buffoni
2
Affiliations
1
University Hospital of Geneva, Geneva 1211, Switzerland. Electronic address: alfredo.addeo@hcuge.ch.
2
Department of Oncology, San Luigi Hospital University of Turin, Turin, Italy.
PMID:
31044707
DOI:
10.1016/S1470-2045(19)30175-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung / surgery*
Dose Fractionation, Radiation
Humans
Lung Neoplasms / surgery*
Radiosurgery*